Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma (PDAC)

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma (PDAC). Study availability and eligibility vary by location and protocol.

69 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma (PDAC) trial results

Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07491445

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 25 locations
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

NCT07644559

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • START- Los Angeles Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 24 locations
View Trial Details
Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 35 locations
View Trial Details
Recruiting

A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07450859

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Siteman Cancer Center (Washington University School of Medicine) St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center - Main Campus New York, United States
  • Thomas Jefferson University, Sidney Kimmel Comprensive Cancer Center, Clinical Trials Office Philadelphia, Pennsylvania, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
View Trial Details
Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05706129

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View Trial Details
Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Recruiting

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

NCT07255404

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Tsinghua Changgung Hospital Beijing, China
  • Sichuan Cancer Hospital Chengdu, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
View all 24 locations
View Trial Details

Related conditions